Quick Answer
ELITE PHARMACEUTICALS INC /NV/ reported Common Stock Shares Outstanding of 1.07 billion shares for the year ending 2025.
- ELITE PHARMACEUTICALS INC /NV/ showed an increase of +0.0% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from ELITE PHARMACEUTICALS INC /NV/'s annual report (Form 10-K), filed with the SEC on June 30, 2025.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2011: 254.78 million shares | Q4 2011: 264.83 million shares | Q2 2012: 346.22 million shares | Q3 2012: 349.66 million shares | Q4 2012: 350.34 million shares | Q2 2013: 395.69 million shares | Q3 2013: 494.71 million shares | Q4 2013: 513.12 million shares | Q2 2014: 567.97 million shares | Q3 2014: 591.65 million shares | Q4 2014: 608.86 million shares | Q2 2015: 659.01 million shares | Q3 2015: 680.76 million shares | Q4 2015: 687.16 million shares | Q2 2016: 730.87 million shares | Q3 2016: 893.57 million shares | Q4 2016: 911.15 million shares | Q2 2017: 780.70 million shares | Q3 2017: 785.95 million shares | Q4 2017: 788.70 million shares | Q2 2018: 804.55 million shares | Q3 2018: 816.86 million shares | Q4 2018: 820.40 million shares | Q2 2019: 828.89 million shares | Q3 2019: 832.84 million shares | Q4 2019: 833.85 million shares | Q2 2020: 840.98 million shares | Q3 2020: 1.01 billion shares | Q4 2020: 1.01 billion shares | Q2 2021: 1.01 billion shares | Q3 2021: 1.01 billion shares | Q4 2021: 1.01 billion shares | Q2 2022: 1.01 billion shares | Q3 2022: 1.01 billion shares | Q4 2022: 1.01 billion shares | Q2 2023: 1.01 billion shares | Q3 2023: 1.01 billion shares | Q4 2023: 1.02 billion shares | Q2 2024: 1.07 billion shares | Q3 2024: 1.07 billion shares | Q4 2024: 1.07 billion shares | Q1 2025: 1.07 billion shares | Q2 2025: 1.07 billion shares | Q3 2025: 1.07 billion shares | Q4 2025: 1.07 billion shares.
- Over the full 15 years of available data (2011 to 2025), ELITE PHARMACEUTICALS INC /NV/'s Common Stock Shares Outstanding has grown by 491.7%.
- Historical annual values: Fiscal year 2025: 1.07 billion shares | Fiscal year 2024: 1.07 billion shares | Fiscal year 2023: 1.01 billion shares | Fiscal year 2022: 1.01 billion shares | Fiscal year 2021: 1.01 billion shares | Fiscal year 2020: 840.40 million shares | Fiscal year 2019: 824.85 million shares | Fiscal year 2018: 802.53 million shares | Fiscal year 2017: 927.93 million shares | Fiscal year 2016: 711.44 million shares | Fiscal year 2015: 631.06 million shares | Fiscal year 2014: 560.14 million shares | Fiscal year 2013: 374.39 million shares | Fiscal year 2012: 331.65 million shares | Fiscal year 2011: 180.55 million shares.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: